H5N1 Avian Flu Becoming More Resistant to Antiviral Drugs

Author: University of Colorado at Boulder
Published: 2009/01/07 - Updated: 2024/04/20
Publication Type: Research, Study, Analysis - Peer-Reviewed: Yes
Contents: Summary - Introduction - Main - Related

Synopsis: A University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs. The rise of resistance to adamantanes, which include the nonprescription drugs amantadine and rimantadane, appears to be linked to Chinese farmers adding the drugs to chicken feed as a flu preventative, according to a paper by researchers from China Agricultural University. According to the Centers for Disease Control in Atlanta, an avian flu pandemic could kill millions of people in America, infect 15 percent to 35 percent of the population and cost well over $100 billion.

Introduction

A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.

Main Digest

The avian flu, an Influenza A subtype dubbed H5N1, is evolving a resistance to a group of antiviral drugs known as adamantanes, one of two classes of antiviral drugs used to prevent and treat flu symptoms, said CU-Boulder doctoral student Andrew Hill, lead study author. The rise of resistance to adamantanes, which include the nonprescription drugs amantadine and rimantadane, appears to be linked to Chinese farmers adding the drugs to chicken feed as a flu preventative, according to a 2008 paper by researchers from China Agricultural University, said Hill.

In contrast, resistance of the avian flu virus to the second, newer class of antiviral drugs that includes oseltamivir, a prescription drug marketed under the brand name Tamiflu, is present, but is not yet prevalent or under positive genetic selection, said Hill of CU-Boulder's ecology and evolutionary biology department. The CU findings should help health administrators around the world plan for the possibility of an avian flu pandemic.

The CU-Boulder study is the first to show H5N1 drug resistance to adamantanes arose through novel genetic mutations rather than an exchange of RNA segments within cells, a process known as re-assortment, said Hill. The research on the mutations, combined with molecular evolution tests and a geographic visualization technique using Google Earth, "provides a framework for analysis of globally distributed data to monitor the evolution of drug resistance," said Hill.

The CU-Boulder-led study appears online in the journal Infection, Genetics and Evolution. Co-authors included CU-Boulder Associate Professor Robert Guralnick, recent CU-Boulder graduate Meredith Wilson, Farhat Habib of Kansas State University and Daniel Janies of Ohio State University.

"As these adamantanes have gotten into nonhuman vectors like birds, the positive selection for resistance to avian flu is rising," said Hill. "If Tamiflu is ever used in the manner of adamantanes, we could conceivably see a similar resistance developing through positive selection."

The research team used an interactive "supermap" using Google Earth technology that portrays the individual gene mutations and spread of the avian flu around the globe, said Guralnick of CU-Boulder's ecology and evolutionary biology department. By projecting genetic and geographic information onto the interactive globe, users can "fly" around the planet to see where resistant H5N1 strains are occurring, said Guralnick, also Hill's doctoral adviser.

For the study, the researchers analyzed 676 whole genomes of Influenza A/H5N1 from National Institutes of Health databases of viruses isolated between 1996 and 2007. The team is comparing how often amino acid sequence changes in genes lead to mutations that affect drug resistance in the H5N1 virus and how often such changes evolve into random mutations that don't affect resistance, Hill said.

First detected in China in 1996, the avian flu has spread throughout Asia and to India, Russia, Pakistan, the Middle East, Africa and Europe by various carriers, including poultry and migratory waterfowl, Hill said. While H5N1 is not highly communicable to humans from birds or between humans, experts are concerned future evolution of this subtype or other subtypes, or genetic re-assortment between subtypes, could make an avian influenza strain more contagious with the potential to cause a pandemic.

"Even if H5N1 is not the flu subtype that develops into the next pandemic, this technique can help us understand the properties of flu viruses and we can use these methods to track mutations in other viruses," said Guralnick. "We can harvest genetic influenza data and monitor it in near real-time, which should give this project some traction to help governments make decisions on managing potential pandemics."

Like the legend of a road map, colors and symbols on the supermap indicate which types of hosts carry the virus or the distribution of genotypes of interest, said Hill. A click by users on viral "isolates" generates computer windows revealing H5N1 mutations linked to positive genetic selection resulting from the spread and use of adamantanes. The information is linked by computer to the National Institutes of Health's GenBank, a database with more than 75 million sequence records.

According to the Centers for Disease Control in Atlanta, an avian flu pandemic could kill millions of people in America, infect 15 percent to 35 percent of the population and cost well over $100 billion.

Attribution/Source(s):

This peer reviewed publication titled H5N1 Avian Flu Becoming More Resistant to Antiviral Drugs was selected for publishing by Disabled World's editors due to its relevance to the disability community. While the content may have been edited for style, clarity, or brevity, it was originally authored by University of Colorado at Boulder and published 2009/01/07 (Edit Update: 2024/04/20). For further details or clarifications, you can contact University of Colorado at Boulder directly at colorado.edu Disabled World does not provide any warranties or endorsements related to this article.

Related Publications

Share This Information To:
𝕏.com Facebook Reddit

Page Information, Citing and Disclaimer

Disabled World is an independent disability community founded in 2004 to provide news and information to people with disabilities, seniors, their family and carers. We'd love for you to follow and connect with us on social media!

Cite This Page (APA): University of Colorado at Boulder. (2009, January 7 - Last revised: 2024, April 20). H5N1 Avian Flu Becoming More Resistant to Antiviral Drugs. Disabled World. Retrieved June 21, 2024 from www.disabled-world.com/news/research/avian-flu-resistance.php

Permalink: <a href="https://www.disabled-world.com/news/research/avian-flu-resistance.php">H5N1 Avian Flu Becoming More Resistant to Antiviral Drugs</a>: A University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.